Inserm is launching its first accelerator of technological research according to the objective that is part of the Institute's strategic plan 2016-2020. This first “Biomedical Ultrasound” ART will be dedicated to research and the use of ultrasound in medicine, particularly in the field of cancer diagnosis and treatment, as well as cardiovascular and neurological diseases.
Explore the outer limits of the brain and matter, create unlimited energy, overcome pain, simulate the unattainable, etc. subjects dear to science fiction that are a now a reality for research laboratories!
ZIKAlliance, a multidisciplinary and multinational research consortium coordinated by Inserm, has received €12 million from the European Union’s Horizon 2020 research and innovation programme to conduct a large-scale 3-year research project on Zika virus (ZIKV) infection in Latin America and the Caribbean.
CNES and Inserm, respectively the institution in charge of proposing and implementing French space policy and the leading biomedical research organisation in Europe, have decided to expand their cooperation in the area of space and health. For the first time, they have signed a framework agreement that will cover the advances in basic research made possible by studying the human being in space, as well as the applications of...
The French National Institute of Health and Medical Research (Inserm) is the only research institution in France listed in the World Top 100 institutions with the most progress in the last 3 years. This is indicated by the Nature Index 2016 Rising Stars, which highlights the big contribution of Inserm researchers to publications in the best 68 journals selected by Nature. This ranking identifies the most brilliant institutions to...
On 11 July 2016, Mr Thierry Mandon, Secretary of State for Higher Education and Research, and the Chairman and CEO of the Institute, Professor Yves Lévy, signed the objectives and performance contract binding Inserm and the French State for the 2016–2020 period. The result of intense exchanges between Inserm and the relevant ministries, the contract defines the broad directions and actions that will be taken by the Institute in...
UN Secretary-General Mr Ban Ki-moon has just announced the creation of a “Global Health Crises” Task Force, which will bring together 3 co-leads and 12 members, including Inserm Chairman and CEO Yves Lévy. The Task Force will ensure the implementation and monitoring of the recommendations of the report, “Protecting humanity from future health crises,” submitted to the UN Secretary-General in February 2016 by the High-level Panel on the Global...
The French Plan for Genomic Medicine 2025 was presented to Prime Minister Manuel Valls by Yves Lévy, President of the National Alliance for Life Sciences and Health (Aviesan) and CEO of Inserm, on 22 June 2016.
How will the traumatic events of the terrorist attacks of 13 November 2015 evolve in people’s memories, whether collective or individual? How does individual memory feed on collective memory and vice versa? Is it possible, by studying cerebral markers, to predict which victims will develop post-traumatic stress disorder and which will recover more quickly?
Cyril Schiever, Chairman of the Board of MSDAVENIR, Professor Yves Lévy, Chairman and CEO of Inserm and Pascale Augé, President of the Executive Board of Inserm Transfert, today signed a strategic framework agreement to support French medical research.This event took place under the patronage and in the presence of Marisol Touraine, French Minister for Social Affairs and Health, and Thierry Mandon, Secretary of State for Higher Education and Research.
Next Generation Scientific Innovation with the 3DEXPERIENCE Platform and Strategic Collaboration to Advance Programs in Aging, Cancer, Genomics and Microbiota